Ruxolitinib Treatment in a Patient with Primary Myelofibrosis Resistant to Conventional Therapies and Splenectomy: A Case Report

A 67-year-old male patient who was diagnosed with primary myelofibrosis 4 years ago did not respond to conventional therapies. The splenomegaly progressively increased, which caused spleen infarctions and led to the decision to perform a splenectomy procedure. After splenectomy, the patient started...

Descripción completa

Detalles Bibliográficos
Autores principales: Aylı, Meltem, Özcan, Muhit, Cengiz Seval, Güldane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451489/
https://www.ncbi.nlm.nih.gov/pubmed/26316489
http://dx.doi.org/10.4274/tjh.2013.0338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451489/
https://www.ncbi.nlm.nih.gov/pubmed/26316489
http://dx.doi.org/10.4274/tjh.2013.0338

Ejemplares similares